Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma. Its Rehabilitation Hospital segment offers therapy and rehabilitation treatments, including rehabilitative services for brain and spinal cord injuries, strokes, amputations, neurological disorders, orthopedic conditions, pediatric congenital or acquired disabilities, and cancer. The company's Outpatient Rehabilitation segment operates rehabilitation clinics that provide physical, occupational, and speech rehabilitation programs and services; and specialized programs, such as functional programs for work related injuries, hand therapy, post-concussion rehabilitation, pediatric and cancer rehabilitation, and athletic training services. Its Concentra segment operates and provides occupational health centers and contract services at employer worksites that deliver occupational medicine, physical therapy, and consumer health services, as well as provides veterans' healthcare services. As of December 31, 2020, the company operated 99 critical illness recovery hospitals in 28 states; 30 rehabilitation hospitals in 12 states; 1,788 outpatient rehabilitation clinics in 37 states and the District of Columbia; and 517 occupational health centers, and 134 onsite clinics at employer worksites states. Select Medical Holdings Corporation was founded in 1996 and is headquartered in Mechanicsburg, Pennsylvania.
IPO Year: 2009
Exchange: NYSE
Website: selectmedical.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/25/2024 | Buy → Hold | The Benchmark Company | |
| 8/20/2024 | $42.00 | Buy | BofA Securities |
| 3/7/2022 | $47.00 → $42.00 | Outperform | RBC Capital |
| 1/18/2022 | $40.00 → $35.00 | Buy | B of A Securities |
| 1/18/2022 | $50.00 → $47.00 | Outperform | RBC Capital |
| 8/10/2021 | $37.00 → $39.00 | Neutral | Credit Suisse |
8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
144 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
144 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
8-K - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
10-Q - SELECT MEDICAL HOLDINGS CORP (0001320414) (Filer)
MECHANICSBURG, Pa., Dec. 3, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Holdings") (NYSE:SEM), today announced that Select Medical Corporation, a wholly-owned subsidiary of Holdings ("Select"), has completed a private offering (the "Offering") of $550.0 million in aggregate principal amount of its 6.250% senior notes due 2032 (the "notes"). The notes are senior unsecured obligations of Select and are guaranteed by certain of Select's existing and future domestic subsidiaries. Select used the net proceeds of the Offering, together with the proceeds from the new incremental term loan and cash on hand, to repay in full the term loans currently outstanding under Select's existing
MECHANICSBURG, Pa., Nov. 25, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced that we have completed our previously announced distribution (the "Distribution") of 104,093,503 shares of common stock of Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) owned by Select Medical Corporation ("SMC"), a wholly owned subsidiary of Select Medical, representing approximately 81.7% of the outstanding shares of Concentra's common stock. After the completion of the Distribution, Select Medical no longer owns any shares of Concentra's common stock. The Distribution was made today to Select Medical's stockholders as o
Concentra Group Holdings Parent, Inc. ("Concentra," "we," "us," or "our") (NYSE:CON) today announced that Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) has completed its previously announced distribution (the "Distribution") of 104,093,503 shares of Concentra's common stock owned by Select Medical Corporation ("SMC"), a wholly owned subsidiary of Select Medical, representing approximately 81.7% of the outstanding shares of Concentra's common stock. After the completion of the Distribution, Select Medical no longer owns any shares of Concentra's common stock. The Distribution was made today to Select Medical's stockholders as of the close of business on November 18, 202
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin
MECHANICSBURG, Pa., Nov. 19, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced the distribution ratio for the previously announced special stock distribution (the "Distribution") to its stockholders of its equity interest in Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE:CON). Based on the shares of Select Medical's common stock outstanding as of November 18, 2024, the record date (the "Record Date") for the Distribution, Select Medical's stockholders will receive 0.806971 shares of Concentra's common stock for every share of Select Medical's common stock held as of the close of business on the Record Date.
MECHANICSBURG, Pa. , Nov. 18, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation, a wholly-owned subsidiary of Holdings ("Select"), has priced a private offering (the "Offering") of $550.0 million in aggregate principal amount of its 6.250% senior notes due 2032 (the "notes"). The Offering is expected to close on December 3, 2024, subject to the satisfaction of customary closing conditions. The notes will be senior unsecured obligations of Select and will be guaranteed by certain of Select's existing and future domestic subsidiaries. Concurrently with the consummation of the Offering, Select intends to amend it
MECHANICSBURG, Pa., Nov. 18, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Holdings") (NYSE: SEM), today announced that Select Medical Corporation ("Select") has commenced a private offering (the "Offering"), subject to market and other customary conditions, of $850 million in aggregate principal amount of senior notes due 2032 (the "notes"). The notes will be senior unsecured obligations of Select and will be guaranteed by certain of Select's existing and future domestic subsidiaries. Concurrently with the consummation of the Offering, Select intends to amend its existing senior secured credit agreement to, among other things, establish a new incremental term loan which will r
MECHANICSBURG, Pa., Nov. 6, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced that its Board of Directors has approved a special stock distribution (the "Distribution") to Select Medical's stockholders of the 104,093,503 shares of common stock of Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) owned by Select Medical Corporation ("SMC"), a wholly owned subsidiary of Select Medical, representing approximately 81.7% of the outstanding shares of Concentra's common stock. The Distribution by Select Medical of the special stock distribution will be made on November 25, 2024 (the "Distribution Date") to all
MECHANICSBURG, Pa., Oct. 31, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its third quarter ended September 30, 2024, and the declaration of a cash dividend. For the third quarter ended September 30, 2024, revenue increased 5.7% to $1,761.2 million, compared to $1,665.7 million for the same quarter, prior year. Income from operations increased 8.6% to $141.1 million for the third quarter ended September 30, 2024, compared to $130.0 million for the same quarter, prior year. Net income increased 33.2% to $81.0 million for the third quarter ended September 30, 2024, compared to $60.8 million for the sam
New SSM Health Rehabilitation Hospital will open in December 2024 MECHANICSBURG, Pa. and OKLAHOMA CITY, Oct. 17, 2024 /PRNewswire/ -- Select Medical Corporation ("Select Medical") and SSM Health today announced the formation of a joint venture partnership to own and operate a 50-bed inpatient rehabilitation hospital in Oklahoma City to be named SSM Health Rehabilitation Hospital – Oklahoma City. The hospital will operate at 700 NW 7th Street and incorporate SSM Health's 12-bed acute rehabilitation unit presently located in St. Anthony Hospital in Oklahoma City. SSM Health Rehabilitation Hospital – Oklahoma City is scheduled to open in December 2024. "Our Mission calls us to continually seek
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G/A - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
SC 13G - SELECT MEDICAL HOLDINGS CORP (0001320414) (Subject)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
4 - SELECT MEDICAL HOLDINGS CORP (0001320414) (Issuer)
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin
MECHANICSBURG, Pa., Nov. 2, 2021 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Parvinderjit Singh Khanuja, M.D. to its Board of Directors (the "Board"), effective on November 1, 2021. Dr. Khanuja's Board term will expire at Select Medical's 2023 Annual Meeting of Stockholders, at which time he will stand for election along with the other director nominees standing for election at that meeting. "We are very pleased to welcome Dr. Khanuja to the Select Medical Board of Directors," said Robert A. Ortenzio, Executive Chairman and Co-Founder of Select Medical. "Dr. Khanuja brings to Select Medical over three decades of experi
MECHANICSBURG, Pa., April 16, 2021 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM) today announced the appointment of Katherine R. Davisson to its Board of Directors (the "Board"), effective immediately. Ms. Davisson's Board term will expire at Select Medical's 2022 Annual Meeting of Stockholders, at which time she will stand for election along with the other director nominees standing for election at that meeting. "We are very pleased to welcome Katherine Davisson to the Select Medical Board of Directors," said Robert A. Ortenzio, Executive Chairman and Co-Founder of Select Medical. "Ms. Davisson brings to Select Medical over two decades of financial servi
MECHANICSBURG, Pa., Oct. 1, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its third quarter ended September 30, 2024 on Thursday, October 31, 2024 after the market closes. Select Medical will host a conference call regarding its third quarter results, as well as its business outlook, on Friday, November 1, 2024, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For
MECHANICSBURG, Pa., July 12, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced an estimate of certain financial results of its wholly-owned subsidiary, Concentra Group Holdings Parent, Inc. ("Concentra"), for the second quarter ended June 30, 2024 in advance of the announcement of Select Medical's actual results, which is expected to occur after market close on Thursday, August 1, 2024. Select Medical expects Concentra's net operating revenue for its second quarter of 2024 to be approximately $477.9 million. Select Medical expects Concentra's income from operations for the second quarter of 2024 to be approximately $
MECHANICSBURG, Pa., June 28, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its second quarter ended June 30, 2024 on Thursday, August 1, 2024 after the market closes. Select Medical will host a conference call regarding its second quarter results, as well as its business outlook, on Friday, August 2, 2024, at 9:00am ET. The conference call will be a live webcast and can be accessed at via this Earnings Call Webcast Link or via link at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For listene
MECHANICSBURG, Pa., June 26, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select") (NYSE:SEM) and Concentra Group Holdings Parent, Inc. ("Concentra"), today announced that Concentra Escrow Issuer Corporation ("Issuer"), a wholly-owned subsidiary of Concentra Health Services, Inc. ("CHSI"), has priced its offering of $650 million aggregate principal amount of 6.875% senior notes due 2032. The notes are being offered in connection with Select's previously announced plan to pursue a separation of Concentra, its wholly-owned occupational health services business (the "Separation"). As a step in the process of effectuating the Separation and subject to satisfaction of certain condit
MECHANICSBURG, Pa., June 25, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select") (NYSE:SEM) and Concentra Group Holdings Parent, Inc. ("Concentra") today announced that Concentra Escrow Issuer Corporation ("Issuer"), a wholly-owned subsidiary of Concentra Health Services, Inc. ("CHSI"), commenced an offering of $750 million in aggregate principal amount of senior notes due 2032. The notes are being offered in connection with Select's previously announced plan to pursue a separation of Concentra, its wholly-owned occupational health services business (the "Separation"). As a step in the process of effectuating the Separation and subject to satisfaction of certain conditions, i
MECHANICSBURG, Pa., May 2, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its first quarter ended March 31, 2024, and the declaration of a cash dividend. For the first quarter ended March 31, 2024, revenue increased 7.4% to $1,788.8 million, compared to $1,665.0 million for the same quarter, prior year. Income from operations increased 28.1% to $194.0 million for the first quarter ended March 31, 2024, compared to $151.5 million for the same quarter, prior year. Net income increased 37.4% to $117.2 million for the first quarter ended March 31, 2024, compared to $85.3 million for the same quarter, prio
MECHANICSBURG, Pa., April 5, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE:SEM), will release the financial results for its first quarter ended March 31, 2024 on Thursday, May 2, 2024 after the market closes. Select Medical will host a conference call regarding its first quarter results, as well as its business outlook, on Friday, May 3, 2024, at 9:00am ET. The conference call will be a live webcast and can be accessed at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For listeners wishing to dial-in via telephone, or participate in the
MECHANICSBURG, Pa., Feb. 22, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) today announced results for its fourth quarter and year ended December 31, 2023 and the declaration of a cash dividend. For the fourth quarter ended December 31, 2023, revenue increased 4.9% to $1,658.9 million, compared to $1,581.5 million for the same quarter, prior year. Income from operations increased 31.5% to $114.3 million for the fourth quarter ended December 31, 2023, compared to $86.9 million for the same quarter, prior year. Net income increased 63.9% to $61.8 million for the fourth quarter ended December 31, 2023, compared to $37.7 million for
MECHANICSBURG, Pa., Jan. 22, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its fourth quarter and full year ended December 31, 2023 on Thursday, February 22, 2024 after the market closes. Select Medical will host a conference call regarding its fourth quarter and full year results, as well as its business outlook, on Friday, February 23, 2024, at 9:00am ET. The conference call will be a live webcast and can be accessed at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For listeners wishing t
MECHANICSBURG, Pa., Oct. 4, 2023 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its third quarter ended September 30, 2023 on Thursday, November 2, 2023 after the market closes. Select Medical will host a conference call regarding its third quarter results, as well as its business outlook, on Friday, November 3, 2023, at 9:00am ET. The conference call will be a live webcast and can be accessed at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com. A replay of the webcast will be available shortly after the call through the same link. For listeners wishing to dial-in via telephone, or part
The Benchmark Company downgraded Select Medical from Buy to Hold
BofA Securities resumed coverage of Select Medical with a rating of Buy and set a new price target of $42.00
RBC Capital reiterated coverage of Select Medical Holdings with a rating of Outperform and set a new price target of $42.00 from $47.00 previously
B of A Securities reiterated coverage of Select Medical Holdings with a rating of Buy and set a new price target of $35.00 from $40.00 previously
RBC Capital reiterated coverage of Select Medical Holdings with a rating of Outperform and set a new price target of $47.00 from $50.00 previously
Credit Suisse reiterated coverage of Select Medical Holdings with a rating of Neutral and set a new price target of $39.00 from $37.00 previously
The Benchmark Company reiterated coverage of Select Medical with a rating of Buy and set a new price target of $44.00 from $40.00 previously
Deutsche Bank reiterated coverage of Select Medical Holdings with a rating of Buy and set a new price target of $46.00 from $42.00 previously
Credit Suisse Group reiterated coverage of Select Medical with a rating of Neutral and set a new price target of $34.00 from $32.00 previously
Credit Suisse reiterated coverage of Select Medical Holdings with a rating of Neutral and set a new price target of $34.00 from $32.00 previously